![N-[4-(4-Azidosalicylamido)butyl]3-(2′-pyridyldithio)propionamide](https://media-prod.aladdinsci.com/media/catalog/product/cache/515ce11dbf2c7bc125424616eb49ad88/N/3/N355738.png)
Determine the necessary mass, volume, or concentration for preparing a solution.
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
Basic Description
| Synonyms | Algiamida | Amid kyseliny salicylove [Czech] | BRN 0742439 | KBio2_003994 | KBioSS_001426 | MFCD00007978 | SR 4326 | Cetamide | SALICYLAMIDE [USP MONOGRAPH] | SPBio_001403 | 4-10-00-00169 (Beilstein Handbook Reference) | Anamid | Salicim | SALICYLAMIDE [J |
|---|---|
| Specifications & Purity | ≥99% |
| Storage Temp | Protected from light |
| Shipped In | Normal |
| Note | 25g卖完停产，不再备货 |
| Product Description | Salicylamide is used in combination with both aspirin and caffeine in the over-the-counter pain remedies. It is used as an analgesic and as an antipyretic. |
Associated Targets(Human)
CTNNBIP1 Tbio Beta-catenin-interacting protein 1 (0 Activities)
CYP1A2 Tchem Cytochrome P450 1A2 (0 Activities)
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
CNR1 Tclin Cannabinoid receptor 1 (0 Activities)
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
DRD2 Tclin D(2) dopamine receptor (0 Activities)
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
DRD4 Tchem D(4) dopamine receptor (0 Activities)
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
CYP3A4 Tclin Cytochrome P450 3A4 (0 Activities)
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
ERBB2 Tclin Receptor tyrosine-protein kinase erbB-2 (0 Activities)
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
ELANE Tclin Neutrophil elastase (0 Activities)
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
EGFR Tclin Epidermal growth factor receptor (0 Activities)
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
AVPR1A Tclin Vasopressin V1a receptor (0 Activities)
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
HMGCR Tclin 3-hydroxy-3-methylglutaryl-coenzyme A reductase (0 Activities)
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
HDAC6 Tclin Histone deacetylase 6 (0 Activities)
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
HRH1 Tclin Histamine H1 receptor (0 Activities)
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
SLCO1B3 Tchem Solute carrier organic anion transporter family member 1B3 (0 Activities)
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
SLC6A3 Tclin Sodium-dependent dopamine transporter (0 Activities)
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
SLC6A4 Tclin Sodium-dependent serotonin transporter (0 Activities)
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
SIGMAR1 Tclin Sigma non-opioid intracellular receptor 1 (0 Activities)
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
PTGS1 Tclin Prostaglandin G/H synthase 1 (0 Activities)
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
CA2 Tclin Carbonic anhydrase 2 (0 Activities)
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
DRD3 Tclin D(3) dopamine receptor (0 Activities)
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
FLT1 Tclin Vascular endothelial growth factor receptor 1 (0 Activities)
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
CHRM3 Tclin Muscarinic acetylcholine receptor M3 (0 Activities)
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
CHRM4 Tclin Muscarinic acetylcholine receptor M4 (0 Activities)
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
ADRA2B Tclin Alpha-2B adrenergic receptor (0 Activities)
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
ADRA2C Tclin Alpha-2C adrenergic receptor (0 Activities)
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
HTR2A Tclin 5-hydroxytryptamine receptor 2A (0 Activities)
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
ADORA2A Tclin Adenosine receptor A2a (0 Activities)
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
ACHE Tclin Acetylcholinesterase (0 Activities)
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
ADRA1B Tclin Alpha-1B adrenergic receptor (0 Activities)
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
ADRA2A Tclin Alpha-2A adrenergic receptor (0 Activities)
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
ADRA1A Tclin Alpha-1A adrenergic receptor (0 Activities)
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
AR Tclin Androgen receptor (0 Activities)
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
MAOA Tclin Amine oxidase [flavin-containing] A (0 Activities)
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
AKR1B1 Tclin Aldose reductase (0 Activities)
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
ADORA1 Tclin Adenosine receptor A1 (0 Activities)
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
HTR1A Tclin 5-hydroxytryptamine receptor 1A (0 Activities)
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
ADORA3 Tchem Adenosine receptor A3 (0 Activities)
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
HTR6 Tchem 5-hydroxytryptamine receptor 6 (0 Activities)
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
HTR2B Tclin 5-hydroxytryptamine receptor 2B (0 Activities)
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
EDNRA Tclin Endothelin-1 receptor (0 Activities)
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
KCNH2 Tclin Potassium voltage-gated channel subfamily H member 2 (0 Activities)
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
OPRD1 Tclin Delta-type opioid receptor (0 Activities)
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
OPRK1 Tclin Kappa-type opioid receptor (0 Activities)
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
OPRM1 Tclin Mu-type opioid receptor (0 Activities)
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
NOS2 Tchem Nitric oxide synthase, inducible (0 Activities)
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
TACR1 Tclin Substance-P receptor (0 Activities)
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
NOS1 Tchem Nitric oxide synthase, brain (0 Activities)
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
PDE5A Tclin Phosphodiesterase 5A (5113 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
CA2 Tclin Carbonic anhydrase II (17698 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ESR1 Tclin Estrogen receptor alpha (17718 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
HMGCR Tclin HMG-CoA reductase (2475 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
NR3C1 Tclin Glucocorticoid receptor (14987 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
INSR Tclin Insulin receptor (5558 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
PGR Tclin Progesterone receptor (8562 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ADRB2 Tclin Beta-2 adrenergic receptor (11824 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
CHRM2 Tclin Muscarinic acetylcholine receptor M2 (10671 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ADRB1 Tclin Beta-1 adrenergic receptor (6630 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
HTR1A Tclin Serotonin 1a (5-HT1a) receptor (14969 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ADRA2A Tclin Alpha-2a adrenergic receptor (9450 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
AR Tclin Androgen Receptor (11781 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
CHRM1 Tclin Muscarinic acetylcholine receptor M1 (12690 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ACE Tclin Angiotensin-converting enzyme (1423 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
DRD2 Tclin Dopamine D2 receptor (23596 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
TYR Tclin Tyrosinase (717 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
TSHR Tclin Thyroid stimulating hormone receptor (29986 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
MAOA Tclin Monoamine oxidase A (11911 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
CNR1 Tclin Cannabinoid CB1 receptor (20913 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
DRD1 Tclin Dopamine D1 receptor (9720 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
DRD4 Tchem Dopamine D4 receptor (7907 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ACHE Tclin Acetylcholinesterase (18204 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
PTGS1 Tclin Cyclooxygenase-1 (9233 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
SLC6A2 Tclin Norepinephrine transporter (10102 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
HRH2 Tclin Histamine H2 receptor (5428 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ADRA1D Tclin Alpha-1d adrenergic receptor (4171 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
HTR1B Tclin Serotonin 1b (5-HT1b) receptor (2801 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
HTR2A Tclin Serotonin 2a (5-HT2a) receptor (14758 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
HTR2C Tclin Serotonin 2c (5-HT2c) receptor (11471 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ADORA1 Tclin Adenosine A1 receptor (17603 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
CALCR Tclin Calcitonin receptor (2215 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
SLC6A4 Tclin Serotonin transporter (12625 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ADRA1A Tclin Alpha-1a adrenergic receptor (8359 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
PTGS2 Tclin Cyclooxygenase-2 (13999 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
HRH1 Tclin Histamine H1 receptor (7573 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ADRA1B Tclin Alpha-1b adrenergic receptor (2912 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
OPRM1 Tclin Mu opioid receptor (19785 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
DRD3 Tclin Dopamine D3 receptor (14368 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
AVPR1A Tclin Vasopressin V1a receptor (5412 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
OPRD1 Tclin Delta opioid receptor (15096 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
OPRK1 Tclin Kappa opioid receptor (16155 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
SLC6A3 Tclin Dopamine transporter (10535 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
KCNH2 Tclin HERG (29587 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
HTR4 Tclin Serotonin 4 (5-HT4) receptor (2068 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ESR2 Tclin Estrogen receptor beta (9272 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
CYSLTR1 Tclin Cysteinyl leukotriene receptor 1 (2118 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ERBB2 Tclin Receptor protein-tyrosine kinase erbB-2 (7851 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
CHRM4 Tclin Muscarinic acetylcholine receptor M4 (6041 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Associated Targets(non-human)
Agtr2 Angiotensin II type 2 (AT-2) receptor (803 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Mc4r Melanocortin receptor 4 (1205 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Ltc4s Leukotriene C4 synthase (1 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Sigmar1 Sigma opioid receptor (160 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Npy1r Neuropeptide Y receptor type 1 (8 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Cckar Cholecystokinin A receptor (90 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Nos2 Nitric oxide synthase, inducible (3573 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Mapk1 MAP kinase ERK2 (650 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Mmp2 Matrix metalloproteinase-2 (12 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Hdac6 Histone deacetylase 6 (222 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Galc Galactocerebrosidase (11 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Mmp9 Matrix metalloproteinase 9 (38 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
pol Human immunodeficiency virus type 1 integrase (9041 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Micrococcus luteus (7463 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Staphylococcus aureus (210822 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Escherichia coli (133304 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Saccharomyces cerevisiae (19171 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Mus musculus (284745 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Rattus norvegicus (775804 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Hepatitis C virus (23859 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Salmonella enterica (1497 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
lef Anthrax lethal factor (7585 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
rep Replicase polyprotein 1ab (378 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
pfk 6-phospho-1-fructokinase (7870 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ARG1 Arginase-1 (70 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Mapt Microtubule-associated protein tau (6 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Rorc Nuclear receptor ROR-gamma (89407 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Glra2 Glycine receptor (1745 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Names and Identifiers
| Pubchem Sid | 488179881 |
|---|---|
| Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/488179881 |
| IUPAC Name | 2-hydroxybenzamide |
| INCHI | InChI=1S/C7H7NO2/c8-7(10)5-3-1-2-4-6(5)9/h1-4,9H,(H2,8,10) |
| InChi Key | SKZKKFZAGNVIMN-UHFFFAOYSA-N |
| Canonical SMILES | C1=CC=C(C(=C1)C(=O)N)O |
| Isomeric SMILES | C1=CC=C(C(=C1)C(=O)N)O |
| WGK Germany | 3 |
| RTECS | VN6475000 |
| PubChem CID | 5147 |
| Molecular Weight | 137.14 |
| Beilstein | 742439 |
| Reaxy-Rn | 742439 |
Certificates
Certificate of Analysis(COA)
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
 C2031133 | Certificate of Analysis | Jan 19, 2024 | S110553 |
| I2215111 | Certificate of Analysis | Jul 28, 2022 | S110553 |
| I2215116 | Certificate of Analysis | Jul 28, 2022 | S110553 |
| I2216583 | Certificate of Analysis | Jul 28, 2022 | S110553 |
| I2216584 | Certificate of Analysis | Jul 28, 2022 | S110553 |
| I2216585 | Certificate of Analysis | Jul 28, 2022 | S110553 |
| I2216586 | Certificate of Analysis | Jul 28, 2022 | S110553 |
| J2424327 | Certificate of Analysis | Jul 28, 2022 | S110553 |
| B2210331 | Certificate of Analysis | Dec 20, 2021 | S110553 |
| B2210332 | Certificate of Analysis | Dec 20, 2021 | S110553 |
| B2210334 | Certificate of Analysis | Dec 20, 2021 | S110553 |
| B2210375 | Certificate of Analysis | Dec 20, 2021 | S110553 |
| B2210387 | Certificate of Analysis | Dec 20, 2021 | S110553 |
| D23261110 | Certificate of Analysis | Dec 20, 2021 | S110553 |
Show more⌵
Chemical and Physical Properties
| Solubility | Soluble in water (2.06 mg/ml at 25°C), chloroform, dimethyl sulfoxide, alcohol, and methanol (100 mg/ml). |
|---|---|
| Sensitivity | Light sensitive. |
| Boil Point(°C) | 182°C/14mmHg |
| Melt Point(°C) | 140°C |
Safety and Hazards(GHS)
| Pictogram(s) | GHS07 |
|---|---|
| Signal | Warning |
| Hazard Statements | H315:Causes skin irritation H319:Causes serious eye irritation H335:May cause respiratory irritation H302:Harmful if swallowed H312:Harmful in contact with skin |
| Precautionary Statements | P261:Avoid breathing dust/fume/gas/mist/vapors/spray. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing. P280:Wear protective gloves/protective clothing/eye protection/face protection. P302+P352:IF ON SKIN: wash with plenty of water. P321:Specific treatment (see ... on this label). P405:Store locked up. P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P271:Use only outdoors or in a well-ventilated area. P270:Do not eat, drink or smoke when using this product. P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing. P403+P233:Store in a well-ventilated place. Keep container tightly closed. P362+P364:Take off contaminated clothing and wash it before reuse. P330:Rinse mouth. P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes. P301+P317:IF SWALLOWED: Get medical help. P317:Get emergency medical help. P337+P317:If eye irritation persists: Get medical help. P332+P317:If skin irritation occurs: Get medical help. P319:Get medical help if you feel unwell. |
| WGK Germany | 3 |
| RTECS | VN6475000 |
| Reaxy-Rn | 742439 |
| Merck Index | 8328 |
Related Documents
Alternative Products
-
5-Bromo-2-hydroxybenzamideStarting at $22.90
- 5-Chlorosalicylamide
Starting at $13.90
- N,N-Diethylsalicylamide
Starting at $21.90
- N-[4-(4-Azidosalicylamido)butyl]3-(2′-pyridyldithio)propionamide
Starting at $488.90
- Salicylamide
Starting at $69.90
- (p-Azidosalicylamido)ethyl-1,3′-dithiopropionic Acid
Starting at $209.90
- 5-Acetylsalicylamide
Starting at $11.90
- 4-Methoxysalicylamide
Starting at $37.90
References
| 1. Ray P, Wright J, Adam J, Bennett J, Boucharens S, Black D, Cook A, Brown AR, Epemolu O, Fletcher D et al.. (2011) Fragment-based discovery of 6-substituted isoquinolin-1-amine based ROCK-I inhibitors.. Bioorg Med Chem Lett, 21 (1): (97-101). [PMID:21145740] [10.1021/op500134e] |
| 2. Zenei Taira,Kazunori Yabe,Yuka Hamaguchi,Kensuke Hirayama,Makoto Kishimoto,Shiro Ishida,Yukari Ueda. (2004-03-30) Effects of Sho-saiko-to extract and its components, Baicalin, baicalein, glycyrrhizin and glycyrrhetic acid, on pharmacokinetic behavior of salicylamide in carbon tetrachloride intoxicated rats.. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 42 ((5)): (803-807). [PMID:15046826] |
| 3. Marica Medić-Sarić,Ana Mornar,Ivona Jasprica. (2004-07-28) Lipophilicity study of salicylamide.. Acta pharmaceutica (Zagreb, Croatia), 54 ((2)): (91-101). [PMID:15274753] |
| 4. V Castro Lopez,J Hadgraft,M J Snowden. (2005-02-24) The use of colloidal microgels as a (trans)dermal drug delivery system.. International journal of pharmaceutics, 292 ((1-2)): (137-147). [PMID:15725560] |
| 5. A Yokoyama,H Hara. (2005-06-04) Multiple fixed drug eruption due to drug combination.. Contact dermatitis, 52 ((6)): (339-341). [PMID:15932587] |
| 6. S Zhang,J H Yang,F Yu,J Zhao,P Jiang,L Chang,C Tang,J Xu. (2006-06-27) Protective role of 3-nitro-N-methyl-salicylamide on isolated rat heart during 4 hours of cold storage and reperfusion.. Transplantation proceedings, 38 ((5)): (1247-1252). [PMID:16797274] |
| 7. Peter L D Wildfong,Bruno C Hancock,Michael D Moore,Kenneth R Morris. (2006-08-23) Towards an understanding of the structurally based potential for mechanically activated disordering of small molecule organic crystals.. Journal of pharmaceutical sciences, 95 ((12)): (2645-2656). [PMID:16924685] |
| 8. Po-Chiao Lin,Mei-Chun Tseng,An-Kai Su,Yu-Ju Chen,Chun-Cheng Lin. (2007-04-04) Functionalized magnetic nanoparticles for small-molecule isolation, identification, and quantification.. Analytical chemistry, 79 ((9)): (3401-3408). [PMID:17402709] |
| 9. Bram Baert,Eric Deconinck,Mireille Van Gele,Marian Slodicka,Paul Stoppie,Samuel Bodé,Guido Slegers,Yvan Vander Heyden,Jo Lambert,Johan Beetens,Bart De Spiegeleer. (2007-09-11) Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.. Bioorganic & medicinal chemistry, 15 ((22)): (6943-6955). [PMID:17827020] |
| 10. E Ono,M Taniguchi,H Mita,K Akiyama. (2008-03-05) Salicylamide-induced anaphylaxis: increased urinary leukotriene E4 and prostaglandin D2 metabolite.. Allergy, 63 ((4)): (480-482). [PMID:18315738] |
| 11. R Dolezal,S Van Damme,P Bultinck,K Waisser. (2008-06-13) QSAR analysis of salicylamide isosteres with the use of quantum chemical molecular descriptors.. European journal of medicinal chemistry, 44 ((2)): (869-876). [PMID:18547684] |
| 12. Peter J McNamara,Rae Ellen Syverson,Kathy Milligan-Myhre,Olga Frolova,Sarah Schroeder,Joshua Kidder,Thanh Hoang,Richard A Proctor. (2009-02-19) Surfactants, aromatic and isoprenoid compounds, and fatty acid biosynthesis inhibitors suppress Staphylococcus aureus production of toxic shock syndrome toxin 1.. Antimicrobial agents and chemotherapy, 53 ((5)): (1898-1906). [PMID:19223628] |
| 13. Yong-Jiang Zhao,Wei Wei,Zhi-Guo Su,Guang-Hui Ma. (2009-06-23) Poly (ethylene glycol) prodrug for anthracyclines via N-Mannich base linker: design, synthesis and biological evaluation.. International journal of pharmaceutics, 379 ((1)): (90-99). [PMID:19540322] |
| 14. Xue-Qin Song,Wen-Kui Dong,Yu-Jie Zhang,Wei-Sheng Liu. (2009-09-11) Synthesis and luminescence properties of lanthanide complexes with a new tripodal ligands featuring salicylamide arms.. Luminescence : the journal of biological and chemical luminescence, 25 ((4)): (328-335). [PMID:19743523] |
| 15. Denis Fourches,Julie C Barnes,Nicola C Day,Paul Bradley,Jane Z Reed,Alexander Tropsha. (2009-12-18) Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.. Chemical research in toxicology, 23 ((1)): (171-183). [PMID:20014752] |
| 16. Jennifer A Jacobsen,Jessica L Fullagar,Melissa T Miller,Seth M Cohen. (2010-12-30) Identifying chelators for metalloprotein inhibitors using a fragment-based approach.. Journal of medicinal chemistry, 54 ((2)): (591-602). [PMID:21189019] |
| 17. Stephanie S Barnes,Christopher M Vogels,Andreas Decken,Stephen A Westcott. (2011-03-25) Addition of boranes to N-aryl-salicylaldimines: intramolecular hydrogenation of imines.. Dalton transactions (Cambridge, England : 2003), 40 ((17)): (4707-4714). [PMID:21431160] |
| 18. J A Murillo Pulgarín,A Alañón Molina,I Sánchez-Ferrer Robles. (2011-05-13) Simultaneous determination of salicylic acid and salicylamide in biological fluids.. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 79 ((5)): (909-914). [PMID:21561802] |
| 19. Carlos Barea,Adriana Pabón,Denis Castillo,Mirko Zimic,Miguel Quiliano,Silvia Galiano,Silvia Pérez-Silanes,Antonio Monge,Eric Deharo,Ignacio Aldana. (2011-07-05) New salicylamide and sulfonamide derivatives of quinoxaline 1,4-di-N-oxide with antileishmanial and antimalarial activities.. Bioorganic & medicinal chemistry letters, 21 ((15)): (4498-4502). [PMID:21724395] |
| 20. Jessica Nilsson,Albert A Shteinman,Eva Degerman,Eva A Enyedy,Tamás Kiss,Ulrich Behrens,Dieter Rehder,Ebbe Nordlander. (2011-11-08) Salicylamide and salicylglycine oxidovanadium complexes with insulin-mimetic properties.. Journal of inorganic biochemistry, 105 ((12)): (1795-1800). [PMID:22056176] |
| 21. Xiaoyan Zhou,Yanling Guo,Zhaohua Shi,Xueqin Song,Xiaoliang Tang,Xiong Hu,Zhentong Zhu,Pengxuan Li,Weisheng Liu. (2011-12-14) Diverse lanthanide coordination polymers tuned by the flexibility of ligands and the lanthanide contraction effect: syntheses, structures and luminescence.. Dalton transactions (Cambridge, England : 2003), 41 ((6)): (1765-1775). [PMID:22159044] |
| 22. Silvia Wein,Rainer Cermak,Siegfried Wolffram,Peter Langguth. (2011-12-23) Chronic quercetin feeding decreases plasma concentrations of salicylamide phase II metabolites in pigs following oral administration.. Xenobiotica; the fate of foreign compounds in biological systems, 42 ((5)): (477-482). [PMID:22188411] |
| 23. José L Castro,Maria R Lopez-Ramirez,Juan F Arenas,Juan Soto,Juan C Otero. (2012-01-25) Evidence of deprotonation of aromatic acids and amides adsorbed on silver colloids by surface-enhanced Raman scattering.. Langmuir : the ACS journal of surfaces and colloids, 28 ((24)): (8926-8932). [PMID:22268552] |
| 24. Yasemin Dündar,Yasemin Özatik,Orhan Özatik,Volkan Ergin,Tijen Önkol,Adnan Menevşe,Kevser Erol,M Fethi Sahin. (2012-04-26) Synthesis and biological evaluation of the salicylamide and salicylic acid derivatives as anti-estrogen agents.. Medicinal chemistry (Shariqah (United Arab Emirates)), 8 ((3)): (481-490). [PMID:22530891] |
| 25. Katja Pajula,Vesa-Pekka Lehto,Jarkko Ketolainen,Ossi Korhonen. (2012-08-08) Computational approach for fast screening of small molecular candidates to inhibit crystallization in amorphous drugs.. Molecular pharmaceutics, 9 ((10)): (2844-2855). [PMID:22867030] |
| 26. Qing-Shan Li,Xian-Hai Lv,Yan-Bin Zhang,Jing-Jun Dong,Wen-Ping Zhou,Yang Yang,Hai-Liang Zhu. (2012-10-03) Identification of novel 3,5-diarylpyrazoline derivatives containing salicylamide moiety as potential anti-melanoma agents.. Bioorganic & medicinal chemistry letters, 22 ((21)): (6596-6601). [PMID:23025996] |
| 27. Saura C Sahu,Jiwen Zheng,Lesley Graham,Lynn Chen,John Ihrie,Jeffrey J Yourick,Robert L Sprando. (2014-02-14) Comparative cytotoxicity of nanosilver in human liver HepG2 and colon Caco2 cells in culture.. Journal of applied toxicology : JAT, 34 ((11)): (1155-1166). [PMID:24522958] |
| 28. Tareisha L Dunlap,Shuai Wang,Charlotte Simmler,Shao-Nong Chen,Guido F Pauli,Birgit M Dietz,Judy L Bolton. (2015-07-03) Differential Effects of Glycyrrhiza Species on Genotoxic Estrogen Metabolism: Licochalcone A Downregulates P450 1B1, whereas Isoliquiritigenin Stimulates It.. Chemical research in toxicology, 28 ((8)): (1584-1594). [PMID:26134484] |
| 29. Denilson F Oliveira,Viviane A Costa,Willian C Terra,Vicente P Campos,Pacelli M Paula,Samuel J Martins. (2019-02-23) Impact of phenolic compounds on Meloidogyne incognita in vitro and in tomato plants.. Experimental parasitology, 199 (17-23). [PMID:30790574] |
| 30. A Mata,A Galindo,J Díaz,J L Marijuan,M J Aguilera. (1995-06-01) [Complete anorectal stenosis due to paracetamol and salicylamide suppositories].. Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, 87 ((6)): (463-464). [PMID:7612370] |
| 31. Milena Jadrijević-Mladar Takac,Drazen Vikić Topić,Tihana Govorcinović. (2004-12-22) FT-IR and NMR spectroscopic studies of salicylic acid derivatives. I. Gentisamide -- a metabolite of salicylamide.. Acta pharmaceutica (Zagreb, Croatia), 54 ((3)): (163-176). [PMID:15610614] |
| 32. Ann H Cory,Joseph G Cory. (2005-03-31) Phenolic compounds, sodium salicylate and related compounds, as inhibitors of tumor cell growth and inducers of apoptosis in mouse leukemia L1210 cells.. In vivo (Athens, Greece), 19 ((1)): (31-35). [PMID:15796154] |
| 33. Ali Reza Zarei,Abbas Afkhami,Nahid Sarlak. (2006-03-11) Simultaneous spectrophotometric determination of paracetamol and salicylamide in human serum and pharmaceutical formulations by a differential kinetic method.. Journal of AOAC International, 88 ((6)): (1695-1701). [PMID:16526453] |
| 34. B Gilbert-López,E J Llorent-Martínez,P Ortega-Barrales,A Molina-Díaz. (2006-09-19) Development of a multicommuted flow-through optosensor for the determination of a ternary pharmaceutical mixture.. Journal of pharmaceutical and biomedical analysis, 43 ((2)): (515-521). [PMID:16978822] |
| 35. Patricia D Sauzem,Pablo Machado,Maribel A Rubin, "Gabriela da S Santanna", Henrique B Faber,Alessandra H de Souza,Carlos F Mello,Paulo Beck,Robert A Burrow,Helio G Bonacorso,Nilo Zanatta,Marcos A P Martins. (2007-09-25) Design and microwave-assisted synthesis of 5-trifluoromethyl-4,5-dihydro-1H-pyrazoles: novel agents with analgesic and anti-inflammatory properties.. European journal of medicinal chemistry, 43 ((6)): (1237-1247). [PMID:17889969] |
| 36. Jihye Kim,Sookjin Kang,Sungchae Hong,Soowhan Yum,Young Mi Kim,Yunjin Jung. (2011-12-14) Structure-activity relationship of salicylic acid derivatives on inhibition of TNF-α dependent NFκB activity: Implication on anti-inflammatory effect of N-(5-chlorosalicyloyl)phenethylamine against experimental colitis.. European journal of medicinal chemistry, 48 (36-44). [PMID:22154834] |